NEW YORK CITY, NEW YORK / ACCESS Newswire / October 30, 2025 / TruMerit President and CEO Peter Preziosi has been elected ...
Novartis will acquire Avidity Biosciences for about US$12 billion to gain its RNA platform and late-stage rare-disease ...
In an era where chronic inflammatory diseases are taking centre stage in healthcare debates, the biologics segment is ...
Physician-led wellness brand brings its evidence-based longevity and recovery model to downtown LA. LOS ANGELES, CA / ACCESS ...
Novo Nordisk has topped Pfizer’s offer for Metsera with a bid of up to US$9 billion, seeking to secure Metsera’s obesity-drug ...
Regeneron and ModeX Therapeutics have joined forces in a collaboration worth over one billion dollars to develop ...
LOS ANGELES, CALIFORNIA / ACCESS Newswire / October 30, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into ...
Medidata Consent, a key part of the Medidata Patient Experience, expedites study start-up, reduces configuration complexity, and improves patient enrollment New York – Oct. 30, 2025 – Medidata, a ...
MESA, ARIZONA / ACCESS Newswire / October 30, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE), a diversified holding company operating at the intersection of technology, wellness, and ...
BOCA RATON, FL / ACCESS Newswire / October 30, 2025 / Entero Therapeutics (NASDAQ:ENTO) has just made one of the boldest moves in its history, a reinvention that trades long biotech timelines for ...
Former Inizio Evoke President of CX joins Supreme Group’s management team to lead platform-wide growth strategy WEST CHESTER, Pa. — Oct. 30, 2025 — Supreme Group, a next-generation agency platform ...
Boehringer Ingelheim licences a novel small-molecule treatment from Kyowa Kirin for fibro-inflammatory and autoimmune diseases in a deal worth up to €410 million.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback